Who
Eric Francois
Director
Company insider
Files Form 4 as: Director, CERo Therapeutics Holdings; Director, CervoMed; Chief Financial Officer, Scynexis.
In numbers
- Trades disclosed
- 23
- Buys
- 3
- Sells
- 0
- Bought
- $50K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Nov 2015
- Last trade
- 4 Mar 2026
- Last filed
- 21 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 21 Apr 2026 | CERo Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,823,278 at $0.00 | filing |
| 4 Mar 2026filed 21 Apr 2026 | CERo Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,823,278 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,300 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,300 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,400 at $0.00 | filing |
| 29 Jan 2021filed 2 Feb 2021 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —300 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —300 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Bought | $3,750600 at $6.25 | filing |
| 25 Nov 2020filed 4 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Code F | $24K3,480 at $6.81 | filing |
| 15 Feb 2020filed 4 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Code F | $9,594979 at $9.80 | filing |
| 31 Jan 2020filed 4 Feb 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
| 15 Feb 2019filed 19 Feb 2019 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 15 Feb 2019filed 19 Feb 2019 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 8 Mar 2018filed 12 Mar 2018 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code P | —4,437 | filing |
| 8 Mar 2018filed 12 Mar 2018 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,662 | filing |
| 8 Mar 2018filed 12 Mar 2018 | SCYX ScynexisBiotechnology | SEC FORM 4 Bought | $10,0005,917 at $1.69 | filing |
| 9 Feb 2018filed 13 Feb 2018 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 31 Jan 2017filed 2 Feb 2017 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 24 Jun 2016filed 28 Jun 2016 | SCYX ScynexisBiotechnology | SEC FORM 4 Bought | $36K15,000 at $2.39 | filing |
News
No headline names them, or the companies they trade most, lately.